The Story Behind the Paper: From a Workshop to a Published Fight Against Malaria
Published in Chemistry
Two years ago, I attended a molecular docking workshop, eager to learn how virtual screening could accelerate the discovery of new drugs. Little did I know that a simple suggestion from the coordinator—"Why don’t you all form a group and continue a project after this?"—would set us on a path leading to a peer-reviewed publication in Discover Chemistry.
Our newly formed team decided to tackle a problem close to home: malaria. In Nigeria, malaria accounts for a staggering burden—30% of childhood deaths, 11% of maternal deaths, and over 60% of clinical visits. With the terrifying rise of artemisinin-resistant Plasmodium falciparum strains, the need for new therapeutic strategies has never been more urgent.
We chose to look for answers in a familiar guardian: the Neem tree (Azadirachta indica). While its traditional uses are well-known, its vast chemical repertoire remained largely unmapped for modern, target-based drug discovery. Our mission was clear: use computational tools to systematically mine neem's 320+ phytochemicals for a specific weapon—an inhibitor of Plasmepsin II, a critical enzyme the malaria parasite uses to digest hemoglobin and survive in our blood.
As the group leader, I witnessed an incredible synergy. We pooled our resources to present initial findings at conferences. Then began the real grind: nights of running docking simulations, analyzing complex pharmacophore models, and tracking the dynamic dance of protein-ligand interactions across 100 nanoseconds of simulation time.
The results were illuminating. Our screen identified Cerebroside C as a potent binder, with the highest predicted affinity. A classic approach might have stopped there. But our deeper analysis revealed a crucial lesson in drug discovery: binding strength alone is not enough.
Through ADMET profiling, we found Cerebroside C would likely have poor bioavailability and be pumped out of cells by P-glycoprotein. Instead, a compound named Apigenin-7-O-β-D-glucoside emerged as the dark horse. It showed strong, stable binding in dynamic simulations, forming a resilient complex with key residues like Asp214 and Tyr77, and—most importantly—it possessed the drug-like properties necessary to potentially become a real medicine.
This research, now published, is more than just a paper. It is a testament to collaborative spirit, from funding our own initial steps to supporting each other through the manuscript process. It highlights the power of computational foresight—using in silico tools to guide the search for therapeutics, saving time and resources. Most importantly, it adds a promising piece to the global puzzle of defeating drug-resistant malaria.
My deepest thanks go to my incredible co-authors and teammates: Garba Dauda, Amina Busola Olorukooba, Iyabo Mobolawa Adebisi, Omobolanie Ibukun Ogundele, Murtala Muhammad Jibril, Aiseosa Kingsley Iqhar, Jamilu Sani, Walter Mdekera Iorjim, Okesola Mary Abiola, Abayomi Emmanuel Adegboyega, and Titilayo Omolara Johnson. This achievement is yours as much as it is mine.
The journey from a workshop idea to a published study reminds us that scientific progress often starts with a simple step: a curious team deciding to work together on a problem that matters.
Read our full open-access story here: https://rdcu.be/eXrW8
DOI: 10.1007/s44371-025-00461-z
#ScienceStory #MalariaResearch #DrugDiscovery #Neem #ComputationalBiology #TeamScience #NigerianResearch #AcademicTwitter #FromWorkshopToPublication
Follow the Topic
-
Discover Chemistry
A fully open access, peer-reviewed journal supporting multidisciplinary research and policy developments across all fields of chemistry.
Related Collections
With Collections, you can get published faster and increase your visibility.
Targeted Medicinal Chemistry: Integrating Computational Approaches for Drug Design and Discovery
Scope and Objectives:
The discovery of new therapeutic agents has increasingly relied on the integration of medicinal chemistry synthesis with computational approaches to accelerate the identification, optimization, and development of biologically active molecules. Recent advances in computational chemistry have significantly improved the efficiency of lead identification and optimization while reducing the cost and time associated with conventional drug discovery.
This Collection aims to highlight cutting-edge research at the interface of synthesis targeted medicinal chemistry and computational sciences, focusing on the rational design, synthesis, biological evaluation, and in silico optimization of novel therapeutic candidates. The collection will provide an interdisciplinary platform for chemists, computational scientists, pharmacologists, structural biologists, and pharmaceutical researchers to present innovative methodologies and discoveries that contribute to next-generation drug development.
The Collection welcomes original research articles, comprehensive reviews, mini-reviews, and perspective articles covering experimental and computational studies that address current challenges in medicinal chemistry and translational drug discovery.
Expected Impact
The proposed collection will serve as a comprehensive resource for emerging methodologies and recent advances in computationally guided medicinal chemistry. It is expected to attract high-quality submissions from international researchers and foster collaborations across academia, industry, and pharmaceutical research organizations. By combining experimental medicinal chemistry with computational approaches, the collection will contribute significantly to accelerating the development of safer and more effective therapeutic agents.
Specific Key Topics:
• Rational drug design and lead optimization
• Computer-aided drug design (CADD)
• Molecular docking and virtual screening
• Molecular dynamics simulations
• Density Functional Theory (DFT) applications in medicinal chemistry
• QSAR and 3D-QSAR modeling
• Pharmacophore modeling
• Artificial intelligence and machine learning in drug discovery
• Green medicinal chemistry
• Bioactive phytochemical
• Natural products as therapeutic leads
• Anticancer drug discovery
• Antimicrobial and antiviral drug development
• Neurodegenerative disease therapeutics
• Anti-inflammatory agents
• Metabolic disease therapeutics
• Protein–ligand interaction studies
• Drug-likeness and toxicity prediction
• Cheminformatics and bioinformatics in medicinal chemistry
• Computational studies supporting synthetic medicinal chemistry
• Novel heterocyclic compounds with therapeutic potential
• Nanomedicine and targeted drug delivery systems
Keywords: Targeted Medicinal Chemistry, Computational Drug Discovery & Design, Pharmacophore Studies, Synthetic Chemistry, Phytochemistry, Natural Product, Molecular Docking, Virtual Screening.
This Collection supports and amplifies research related to SDG 3, SDG 4, SDG 9, and SDG 12.
Publishing Model: Open Access
Deadline: Jul 25, 2027
Selected Papers from International Conference on Green Chemistry and Sustainable Development
Green chemistry advances sustainable development by enabling innovative chemical processes that minimize toxicity, waste, and resource consumption. The International Conference on Green Chemistry and Sustainable Development brings together scientists, researchers, industry leaders, and policymakers from around the world to share innovations, research findings, and strategies for promoting environmentally friendly chemical practices. The conference focuses on advancing green technologies, reducing environmental impact, providing renewable energy solutions, waste management, and supporting global efforts toward sustainable economic and social development. It serves as a platform for collaboration, education, and the exchange of ideas aimed at building a greener and more sustainable future through responsible scientific practices and sustainable industrial development.
Homepage: https://www.acsfuo.org/abstract
Keywords:Sustainability, Renewable resources, Biodegradable materials, green chemistry, Waste reduction, Renewable energy, Eco-friendly processes
This Collection supports and amplifies research related to SDG 7, SDG 9, SDG 10, SDG 13, and SDG 15.
Publishing Model: Open Access
Deadline: Nov 30, 2026